Applications from the field of Pharma & Biopharma focused on LC/MS - page 22

Process Monitoring of Monoclonal Antibody Subunits for Fast, Critical Quality Attribute Monitoring Using the ACQUITY QDa Detector

Applications

| 2024 | Waters

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma

Characterization of Forced Degradation Impurities of Glucagon-Like Peptide-1 Agonists by LC/Q-TOF Mass Spectrometry

Applications

| 2024 | Agilent Technologies

LC/MS, LC/MS/MS, LC/HRMS, LC/TOF

Instrumentation

LC/MS, LC/MS/MS, LC/HRMS, LC/TOF

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Evaluating IonHance Hexafluoroisopropanol (HFIP) for Enhanced LC-MS Oligonucleotide Analysis

Applications

| 2024 | Waters

Standards and chemicals, LC/MS

Instrumentation

Standards and chemicals, LC/MS

Manufacturer

Waters

Industries

Pharma & Biopharma

Automatic Optimization of Gradient Conditions by AI Algorithm on Synthetic Peptide and Impurities

Applications

| 2024 | Shimadzu

Software, LC/MS, LC/SQ

Instrumentation

Software, LC/MS, LC/SQ

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Oligonucleotide Mass Confirmation and Impurity Identification

Applications

| 2024 | Agilent Technologies

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

LC/MS Based Characterization Workflow of GLP-1 Therapeutic Peptide Liraglutide and Its Impurities

Applications

| 2024 | Agilent Technologies

LC/MS, LC/HRMS, LC/MS/MS, LC/TOF

Instrumentation

LC/MS, LC/HRMS, LC/MS/MS, LC/TOF

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Extending the Analytics of Biopharmaceutical QA/QC Labs with the ACQUITY™ QDa™ II Mass Detector

Applications

| 2024 | Waters

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma

Streamlining Impurity Analysis in Atorvastatin with the ACQUITY™ QDa™ II Mass Detector for Enhanced Detection and Quantification

Applications

| 2024 | Waters

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma

Method Development of Proteolysis Targeting Chimera (PROTAC) Compound ARV-825 Forced Degradation Sample Using the Systematic Screening Protocol

Applications

| 2024 | Waters

LC/MS, LC/SQ

Instrumentation

LC/MS, LC/SQ

Manufacturer

Waters

Industries

Pharma & Biopharma

Development of Separation Methods for GLP-1 Synthetic Peptides Utilizing a Systematic Protocol and MaxPeak™ High Performance Surface Technology

Applications

| 2024 | Waters

LC/MS, LC/SQ, HPLC

Instrumentation

LC/MS, LC/SQ, HPLC

Manufacturer

Waters

Industries

Pharma & Biopharma